About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 4626 record(s)
Req # A-2019-001494
Adverse Drug Reaction (ADR). Report number: E2B_02344958.Organization: Health Canada
September 2021
Req # A-2019-001747
All correspondence with the Minister of Health and Deputy Minister Stephen Lucas, between November 2019 and January 2020, excluding letters from the public, regarding the national dental care plan.Organization: Health Canada
September 2021
Req # A-2019-001996
The "Ready to Build" letters, if applicable, that would have been sent to the below identified licenced producers of medical marijuana under the authority of the (then) Marijuana for Medical Purposes Regulations (MMPR since repealed).…Organization: Health Canada
September 2021
Req # A-2020-000465
Adverse Reaction Reports (AERs). Report numbers: E2B_02590570, E2B_02445649, E2B_02474428, E2B_02474529, E2B_02500218, E2B_02503231, E2B_02503569, E2B_02504419, E2B_02510541, E2B_02519200, E2B_02524146, E2B_02524346, E2B_02527704, E2B_02532286,…Organization: Health Canada
September 2021
Req # A-2020-000498
Adverse Reaction Reports (AERs). Report numbers: E2B_03012755, E2B_02900556, E2B_02803753, E2B_03031486, E2B_02832171, E2B_02784536.Organization: Health Canada
September 2021
Req # A-2020-000575
Adverse Reaction Reports (AERs). Report numbers: 000733028, 000732802, 000619318, E2B_01480563, E2B_02831793, E2B_02839759, E2B_02840136, 000736688, E2B_02954367.Organization: Health Canada
September 2021
Req # A-2020-000619
Adverse Reaction Reports (AERs). Report numbers: E2B_03056590, E2B_03056592, E2B_03069154, E2B_03070776.Organization: Health Canada
September 2021
Req # A-2020-000620
Adverse Reaction Reports (AERs). Report numbers: E2B_03074640, E2B_03074834, E2B_03077865.Organization: Health Canada
September 2021
Req # A-2020-000630
Electronic versions of the reviewer reports for the approval of Effexor.Organization: Health Canada
September 2021
Req # A-2020-000704
Electronic versions of the reviewer reports for the approval of Cipralex.Organization: Health Canada
September 2021